Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy

Clinical progressive disease (cPD) occurs during neoadjuvant chemotherapy (NAC) in 3%–5% of triple‐negative breast cancer (TNBC) patients. We aimed to identify the histopathological and immunohistochemical parameters that are correlated with the TNBC that showed cPD. We identified 22 TNBCs that show...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Sci
Egile Nagusiak: Tanabe, Yuko, Tsuda, Hitoshi, Yoshida, Masayuki, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Yamamoto, Seiichiro, Kinoshita, Takayuki, Fujiwara, Yasuhiro, Tamura, Kenji
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497804/
https://ncbi.nlm.nih.gov/pubmed/28474753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13274
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak